Safi Biotherapeutics Inc
Safi Biotherapeutics is an early stage biotech company developing cell therapies from hematopoietic progenitor sources.
Safi Biotherapeutics Inc
This company manufactures tailored blood cells on-demand, addressing blood shortages and specific patient needs.
About
Needs Assessment
Active buying signals and potential business opportunities
Technology Requirements
Bioprocessing equipment
Cryostorage solutions
Cell culture equipment
Software for bioprocessing optimization
Quality control and testing equipment for cell therapies
Service Requirements
Cell development process optimization
Cost reduction consulting
Regulatory consulting for cell therapy products
Training on bioprocessing and cell therapy manufacturing
Consulting on scale-up strategies for cell manufacturing
Infrastructure Requirements
Manufacturing facilities for cell therapy products
Scale-up of cell culture and manufacturing processes
Integration with existing healthcare infrastructure for blood transfusions
Cloud infrastructure for data management and analysis
Enhanced security measures for cell therapy manufacturing and storage
Talent Requirements
Experts in blood stem cell expansion
Bioprocessing engineers
Specialists in cryostorage
Regulatory affairs specialists for cell therapies
Manufacturing specialists for cell therapy production
AI Insights
Growth Trajectory
With $5M in seed funding and collaborations with ARMI | BioFabUSA, the company exhibits a high-growth trajectory within the cell therapy manufacturing sector.
Market Opportunity
The company's focus on addressing blood shortages and developing alternatives to donated blood positions it strongly in a market with unmet needs.
Access Our Live VC Funding Database
30,000+ funded startups
tracked in the last 3 months
B2B verified emails
of key decision makers
Growth metrics
Real-time company performance data
Live updates
of new VC funding rounds
Advanced filters
for sophisticated queries
API access
with multiple export formats